Share this:
On Friday, Sept. 17, the Food and Drug Administration's (FDA) advisory panel rejected a proposal to give Pfizer COVID-19 vaccine boosters to the general public. But the panel recommend boosters for people aged 65 and older — and for other high-risk groups — six months after the initial vaccination series. That includes health care workers. The recommendation will go before the FDA for final approval.
FDA approval is just one step in determining whether booster shots will be made available. The Advisory Committee on Immunization Practices (ACIP) will refine the recommendations for booster shots and provide guidance to health care providers, pharmacies and other COVID-19 vaccine providers. ACIP has scheduled a meeting for Sept. 22-23.
"It's a bit of a complicated path," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "But we're exercising caution before we proceed into boosters for everyone, and the reason for that is because we do our best to follow the science." The FDA panel requested more safety data on the use of boosters.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses booster recommendations and other COVID-19 updates.
Watch: Dr. Poland discuss COVID-19 boosters.
__________________________________
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
Research disclosures for Dr. Gregory Poland.
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
Learn more about tracking COVID-19 and COVID-19 trends.
Related Articles
